Sunday, November 17, 2024
Home Tags $RVVTF

Tag: $RVVTF

Revive Therapeutics
Superbug News - CoronaVirus Watch List

Revive Therapeutics Gains 25% on Positive FDA Comments.

Editor / Curator -
2022 Watch List

Institutional Analyst Newsletter. April 14, 2022.

Editor / Curator -
Revive Therapeutics
2022 Watch List

Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for...

Editor / Curator -
2022 Watch List

Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next...

Editor / Curator -
Revive Therapeutics $RVVTF
All News

Amazing Sales of Paxlovid (CBS News).

Editor / Curator -

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.